Alerus Financial’s Edwards Lifesciences EW Stock Holding History

Alerus Financial’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.81K	Buy	+20	New	+$1.68K	﹤0.01%	451
2026 Q1	–	Sell	-22	Closed	-$1.88K	–	524
2025 Q4	$1.88K	Hold	22	–	–	﹤0.01%	458
2025 Q3	$1.71K	Buy	+22	New	+$1.72K	﹤0.01%	485
2022 Q2	–	Sell	-17,720	Closed	-$2.09M	–	175
2022 Q1	$2.09M	Sell	17,720 -12,202	-41%	-$1.37M	0.18%	117
2021 Q4	$3.88M	Buy	29,922 +1,138	+4%	+$133K	0.32%	82
2021 Q3	$3.26M	Sell	28,784 -23	-0.1%	-$2.63K	0.3%	85
2021 Q2	$2.98M	Sell	28,807 -11,498	-29%	-$1.08M	0.3%	83
2021 Q1	$3.37M	Buy	40,305 +8,852	+28%	+$748K	0.36%	76
2020 Q4	$2.87M	Buy	31,453 +16,706	+113%	+$1.39M	0.29%	89
2020 Q3	$1.18M	Buy	14,747 +5,516	+60%	+$430K	0.13%	120
2020 Q2	$638K	Buy	+9,231	New	+$656K	0.08%	131

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Alerus Financial's EW Position: Q2 2026 in Review

Alerus Financial opened a new position in Edwards Lifesciences (EW) in Q2 2026: 20 shares worth $1.81K. The stake represents ﹤0.01% of the portfolio and ranks #451 among its holdings. This is a return to the name: Alerus Financial previously reported a position in EW as recently as Q4 2025.

Alerus Financial first reported a position in EW in Q2 2020 and has held it in 11 quarters since. The position peaked at $3.88M in Q4 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Alerus Financial held 20 shares of Edwards Lifesciences worth $1.81K as of Q2 2026.
Edwards Lifesciences was a new Alerus Financial position in Q2 2026.
Edwards Lifesciences made up ﹤0.01% of Alerus Financial's portfolio in Q2 2026, its #451 holding.
Alerus Financial first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 11 quarters since.
Alerus Financial's Edwards Lifesciences position peaked at $3.88M in Q4 2021.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Alerus Financial's 13F filing for Q2 2026, filed 14 Aug 2026.